Director

• Provide strategic leadership for the Pharmacometrics group within Quantitative Pharmacology and Pharmacometrics (QP2) to drive model-informed drug discovery and development (MIDD).
• Guide and direct a team of approximately 5–6 pharmacometricians to achieve results on major program drivers.
• Identify and implement novel quantitative approaches (comparator modeling, clinical trial simulations, quantitative systems pharmacology, disease progression models, AI and machine learning methods) to improve cycle time, cost/size and number of trials.
• Drive implementation of tools and regulatory frameworks to support rapid approvals and Go/No Go decisions.
• Foster collaboration within QP2, remove barriers on portfolio or scientific priorities, and initiate/manage external collaborations and external outreach to the scientific pharmacometrics community.
• Evaluate and maintain quality systems and IT infrastructure to support emerging capabilities.
• Responsible for priority-setting, performance management, hiring, retention, and talent development for direct reports.
• Apply traditional and state-of-the-art pharmacometric approaches across portfolio from discovery through life-cycle management.

Director, Pharmacometrics

Senior Director, PMO

VP, Energy Technical Director

Director, RWE/Epi Scientist, RSV, COVID, FLU & Pipeline

Senior Director, Automation

Senior Director, Automation